These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36636437)

  • 1. Burden of Cardiovascular Disease in Immune Checkpoint Inhibitor-Treated Patients: Reconciling Adjudicated and Coded Outcomes.
    Kondapalli L; Hsia J; Miller R; Flaig TW; Bonaca MP
    JACC CardioOncol; 2022 Dec; 4(5):649-656. PubMed ID: 36636437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy.
    Lee C; Drobni ZD; Zafar A; Gongora CA; Zlotoff DA; Alvi RM; Taron J; Rambarat PK; Schoenfeld S; Mosarla RC; Raghu VK; Hartmann SE; Gilman HK; Murphy SP; Sullivan RJ; Faje A; Hoffmann U; Zhang L; Mayrhofer T; Reynolds KL; Neilan TG
    JACC CardioOncol; 2022 Dec; 4(5):660-669. PubMed ID: 36636443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary and aortic calcification are associated with cardiovascular events on immune checkpoint inhibitor therapy.
    Schiffer WB; Deych E; Lenihan DJ; Zhang KW
    Int J Cardiol; 2021 Jan; 322():177-182. PubMed ID: 32800916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study.
    Guimarães PO; Krishnamoorthy A; Kaltenbach LA; Anstrom KJ; Effron MB; Mark DB; McCollam PL; Davidson-Ray L; Peterson ED; Wang TY
    JAMA Cardiol; 2017 Jul; 2(7):750-757. PubMed ID: 28538984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors.
    Reyes-Gibby CC; Qdaisat A; Ferrarotto R; Fadol A; Bischof JJ; Coyne CJ; Lipe DN; Hanna EY; Shete S; Abe JI; Yeung SJ
    Head Neck; 2024 Mar; 46(3):627-635. PubMed ID: 38151809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor-associated myocarditis.
    Zhao SH; Yun H; Chen CZ; Chen YY; Lin JY; Zeng MS; Liu TS; Pan CZ; Jin H
    Eur Radiol; 2022 Nov; 32(11):7657-7667. PubMed ID: 35567603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States.
    Jain P; Gutierrez Bugarin J; Guha A; Jain C; Patil N; Shen T; Stanevich I; Nikore V; Margolin K; Ernstoff M; Velcheti V; Barnholtz-Sloan J; Dowlati A
    ESMO Open; 2021 Oct; 6(5):100252. PubMed ID: 34461483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
    Thavendiranathan P; Zhang L; Zafar A; Drobni ZD; Mahmood SS; Cabral M; Awadalla M; Nohria A; Zlotoff DA; Thuny F; Heinzerling LM; Barac A; Sullivan RJ; Chen CL; Gupta D; Kirchberger MC; Hartmann SE; Weinsaft JW; Gilman HK; Rizvi MA; Kovacina B; Michel C; Sahni G; González-Mansilla A; Calles A; Fernández-Avilés F; Mahmoudi M; Reynolds KL; Ganatra S; Gavira JJ; González NS; García de Yébenes Castro M; Kwong RY; Jerosch-Herold M; Coelho-Filho OR; Afilalo J; Zataraín-Nicolás E; Baksi AJ; Wintersperger BJ; Calvillo-Arguelles O; Ederhy S; Yang EH; Lyon AR; Fradley MG; Neilan TG
    J Am Coll Cardiol; 2021 Mar; 77(12):1503-1516. PubMed ID: 33766256
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival.
    Sussman TA; Li H; Hobbs B; Funchain P; McCrae KR; Khorana AA
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33436486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis.
    Dolladille C; Akroun J; Morice PM; Dompmartin A; Ezine E; Sassier M; Da-Silva A; Plane AF; Legallois D; L'Orphelin JM; Alexandre J
    Eur Heart J; 2021 Dec; 42(48):4964-4977. PubMed ID: 34529770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunction.
    Andres MS; Ramalingam S; Rosen SD; Baksi J; Khattar R; Kirichenko Y; Young K; Yousaf N; Okines A; Huddart R; Harrington K; Furness AJS; Turajlic S; Pickering L; Popat S; Larkin J; Lyon AR
    Cardiooncology; 2022 Nov; 8(1):21. PubMed ID: 36424659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial.
    Held C; White HD; Stewart RAH; Davies R; Sampson S; Chiswell K; Silverstein A; Lopes RD; Heldestad U; Budaj A; Mahaffey KW; Wallentin L;
    Am Heart J; 2019 Feb; 208():65-73. PubMed ID: 30572273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Existing Cardiovascular Conditions as Clinical Predictors of Myocarditis Reporting with Immune Checkpoint Inhibitors: A VigiBase Study.
    Noseda R; Ruinelli L; Gaag LCV; Ceschi A
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33238481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor-induced Myocarditis.
    Cadour F; Cautela J; Rapacchi S; Varoquaux A; Habert P; Arnaud F; Jacquier A; Meilhac A; Paganelli F; Lalevée N; Scemama U; Thuny F
    Radiology; 2022 Jun; 303(3):512-521. PubMed ID: 35230185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach.
    Murtagh G; deFilippi C; Zhao Q; Barac A
    Front Cardiovasc Med; 2024; 11():1350585. PubMed ID: 38410245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system.
    Michel L; Totzeck M; Lehmann L; Finke D
    Herz; 2020 Nov; 45(7):645-651. PubMed ID: 32533218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.
    Vasbinder A; Chen Y; Procureur A; Gradone A; Azam TU; Perry D; Shadid H; Anderson E; Catalan T; Blakely P; Nelapudi N; Fardous M; Bretagne MC; Adie SK; Pogue KT; Leja M; Yentz S; Schneider B; Fecher LA; Lao CD; Salem JE; Hayek SS
    JACC CardioOncol; 2022 Dec; 4(5):689-700. PubMed ID: 36636441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE IMPACT OF ROUTINE CARDIAC TROPONIN I-BASED CARDIOTOXICITY SCREENING ON CLINICAL OUTCOMES IN PATIENTS ON CANCER IMMUNOTHERAPY.
    Ivanovic M; Chan A; Cheng E; Xu S; Lee C; You J; Franquiz M; Fazal M; Batchelder R; Wu SM; Reddy SA; Katsumoto T; Ramchandran K; Colevas AD; Khan SA; Fan AC; Cheng P; Wakelee H; Witteles R; Neal JW; Waliany S; Zhu H
    medRxiv; 2024 Jan; ():. PubMed ID: 38343840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
    Gaba P; Bhatt DL; Giugliano RP; Steg PG; Miller M; Brinton EA; Jacobson TA; Ketchum SB; Juliano RA; Jiao L; Doyle RT; Granowitz C; Tardif JC; Ballantyne CM; Pinto DS; Budoff MJ; Gibson CM
    J Am Coll Cardiol; 2021 Oct; 78(15):1525-1537. PubMed ID: 34620410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.